AFP and neoplasm: It is clear from a clinical standpoint, that tumors that continue to express high levels of AFP despite locoregional therapy have concerning tumor biology, which may warrant more aggressive locoregional therapy, consideration of systemic therapies, as well as avoidance of liver transplantation.